Page last updated: 2024-11-12
gymnasterkoreayne b
Description
gymnasterkoreayne B: from Gymnaster koraiensis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (3)
Synonym |
(5s,6z)-1-(3-methyloxiran-2-yl)tetradeca-6,13-dien-1,3-diyn-5-ol |
CHEMBL452639 |
gymnasterkoreayne b |
Protein Targets (1)
Other Measurements
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
AID546826 | Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells assessed as drug level required to double specific enzyme activity | 2010 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
| SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities. |
AID546825 | Cytotoxicity against mouse Hepa-1c1c7 cells | 2010 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
| SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities. |
AID546824 | Chemoprevention index, ratio of IC50 for mouse Hepa-1c1c7 cells to drug level required to double specific NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells | 2010 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
| SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities. |
AID335514 | Cytotoxicity against mouse L1210 cells after 48 hrs by WST-1 assay | 2002 | Journal of natural products, Jun, Volume: 65, Issue:6
| Gymnasterkoreaynes A-F, cytotoxic polyacetylenes from Gymnaster koraiensis. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.84 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.63 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |